Dr. Martens plc (DOCS), the iconic British footwear brand listed on the London Stock Exchange and a constituent of the FTSE 250, has published its total voting rights disclosure in accordance with FCA Disclosure Guidance and Transparency Rule 5.6.1. The company confirms its issued ordinary share capital stands at 968,121,259 ordinary shares of £0.01 each, with every share carrying one voting right. Crucially, the company holds no shares in Treasury, meaning the full 968,121,259 shares represent the active voting denominator. Shareholders will use this figure to assess whether they are required to notify the FCA of interests or changes in interests under the Transparency Rules.

Key Points

  • Dr. Martens plc (DOCS) — FTSE 250, London Stock Exchange main market
  • Total issued ordinary share capital confirmed at 968,121,259 shares of £0.01 each, each carrying one voting right
  • No Treasury shares held; the full 968,121,259 shares form the regulatory denominator for shareholder notification thresholds
  • Investors should monitor any subsequent changes to this denominator figure in future monthly disclosures

Dr. Martens Discloses 968,121,259-Share Voting Denominator Under FCA Transparency Rules

The disclosure was made under FCA Disclosure Guidance and Transparency Rule 5.6.1, which requires listed companies to publish their total voting rights monthly or whenever the figure changes. Dr. Martens confirms that as at the date of the announcement, its entire issued ordinary share capital of 968,121,259 shares carries voting rights, with no shares held in Treasury that would otherwise reduce that denominator. Shareholders and institutional investors who hold, or are approaching, notifiable thresholds in the company must use this figure — 968,121,259 — to calculate whether their stake triggers a disclosure obligation to the FCA.

No Treasury Shares Held by the Northamptonshire-Founded FTSE 250 Footwear Group

Dr. Martens' confirmation that it holds zero Treasury shares is a notable feature of this update. Treasury shares, when held, reduce the effective voting denominator, which can affect the thresholds at which shareholders must declare changes in their interests. With no such reduction in place, the denominator remains at the full 968,121,259 figure. Dr. Martens operates across more than 60 countries, employs approximately 3,600 people, and sells through Direct-to-Consumer retail, ecommerce, and wholesale channels, with its heritage 'Made in England' range still manufactured at its original Northamptonshire factory.

Brand Heritage and Share Structure Context for Dr. Martens Investors

Founded in Northamptonshire, Dr. Martens produced its first 1460 boot on 1 April 1960. Today the brand's collections span iconic silhouettes — including the 1460 boot, 1461 shoe, 2976 Chelsea boot, and Adrian loafer — as well as newer franchises and accessories. The company's ordinary shares each carry a nominal value of £0.01, and the single-class, one-share-one-vote structure means all 968,121,259 shares carry equal rights. Investors tracking governance and capital structure will note the straightforward voting architecture, which carries no dual-class complexity.